Both animal studies and clinical data have established that mutations in ENG or ALK1 are responsible for the formation of the abnormal vasculature seen in the majority of patients with HHT [4]–[6]. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.